Published in BMC Public Health on December 13, 2011
Cost-effectiveness of novel first-line treatment regimens for tuberculosis. Int J Tuberc Lung Dis (2013) 1.52
Timing, rates, and causes of death in a large South African tuberculosis programme. BMC Infect Dis (2014) 0.91
Promoting operational research through fellowships: a case study from the South-East Asia Union Office. Public Health Action (2015) 0.82
Population-level impact of shorter-course regimens for tuberculosis: a model-based analysis. PLoS One (2014) 0.80
Early Mortality during Initial Treatment of Tuberculosis in Patients Co-Infected with HIV at the Yaoundé Central Hospital, Cameroon: An 8-Year Retrospective Cohort Study (2006-2013). PLoS One (2015) 0.80
Time to Death and Associated Factors among Tuberculosis Patients in Dangila Woreda, Northwest Ethiopia. PLoS One (2015) 0.77
High mortality among tuberculosis patients on treatment in Nigeria: a retrospective cohort study. BMC Infect Dis (2017) 0.75
Factors Associated with Fatality during the Intensive Phase of Anti-Tuberculosis Treatment. PLoS One (2016) 0.75
HAART, DOTS and renal disease of patients co-infected with HIV/AIDS and TB in the South West Region of Cameroon. BMC Public Health (2015) 0.75
Deaths during tuberculosis treatment among paediatric patients in a large tertiary hospital in Nigeria. PLoS One (2017) 0.75
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet (2007) 20.57
Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis (2009) 5.75
Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS (2001) 5.61
The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med (2011) 4.91
Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health (2007) 4.13
Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis (2002) 3.89
Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn (2007) 3.31
Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. Lancet (2001) 2.72
Does antiretroviral treatment reduce case fatality among HIV-positive patients with tuberculosis in Malawi? Int J Tuberc Lung Dis (2007) 2.21
Implications of the global increase of diabetes for tuberculosis control and patient care. Trop Med Int Health (2010) 1.96
Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba Hospital, Malawi. Trans R Soc Trop Med Hyg (1998) 1.89
High early death rate in tuberculosis patients in Malawi. Int J Tuberc Lung Dis (2001) 1.78
Risk factors for death during tuberculosis treatment in Orel, Russia. Int J Tuberc Lung Dis (2004) 1.76
Risk factors for treatment default among re-treatment tuberculosis patients in India, 2006. PLoS One (2010) 1.64
Risk factors for death among tuberculosis cases: analysis of European surveillance data. Eur Respir J (2008) 1.52
Mortality among tuberculosis patients on treatment in Singapore. Int J Tuberc Lung Dis (2009) 1.40
Registering initial defaulters and reporting on their treatment outcomes. Int J Tuberc Lung Dis (2009) 1.35
Survival analysis and risk factors for death in tuberculosis patients on directly observed treatment-short course. Indian J Med Sci (2009) 1.17
Excess mortality and risk factors for mortality among a cohort of TB patients from rural south India. Int J Tuberc Lung Dis (2008) 1.15
Tuberculosis outcomes in Taipei: factors associated with treatment interruption for 2 months and death. Int J Tuberc Lung Dis (2009) 1.12
Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med (2006) 24.38
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS (2008) 13.25
True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bull World Health Organ (2007) 6.81
Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS (2006) 5.87
Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS (2006) 5.13
Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science (2010) 5.13
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach. Lancet (2011) 5.00
The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med (2011) 4.91
Operational research in low-income countries: what, why, and how? Lancet Infect Dis (2009) 4.56
Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi. Bull World Health Organ (2006) 4.45
Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science (2013) 3.90
The HIV-associated tuberculosis epidemic--when will we act? Lancet (2010) 3.82
Using touchscreen electronic medical record systems to support and monitor national scale-up of antiretroviral therapy in Malawi. PLoS Med (2010) 3.53
Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med (2012) 3.44
The burden of selected chronic non-communicable diseases and their risk factors in Malawi: nationwide STEPS survey. PLoS One (2011) 3.21
Unacceptable attrition among WHO stages 1 and 2 patients in a hospital-based setting in rural Malawi: can we retain such patients within the general health system? Trans R Soc Trop Med Hyg (2010) 2.96
Providing universal access to antiretroviral therapy in Thyolo, Malawi through task shifting and decentralization of HIV/AIDS care. Trop Med Int Health (2010) 2.92
Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi. AIDS (2003) 2.90
Task shifting for antiretroviral treatment delivery in sub-Saharan Africa: not a panacea. Lancet (2008) 2.89
Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet (2012) 2.83
New vision for Revised National Tuberculosis Control Programme (RNTCP): Universal access - "reaching the un-reached". Indian J Med Res (2012) 2.83
Assessing the quality of data aggregated by antiretroviral treatment clinics in Malawi. Bull World Health Organ (2008) 2.62
Is operational research delivering the goods? The journey to success in low-income countries. Lancet Infect Dis (2012) 2.62
A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat Med (2010) 2.62
Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension. J Hypertens (2014) 2.54
Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi model. Trans R Soc Trop Med Hyg (2004) 2.51
Bi-directional screening for tuberculosis and diabetes: a systematic review. Trop Med Int Health (2010) 2.38
Patient retention and attrition on antiretroviral treatment at district level in rural Malawi. Trans R Soc Trop Med Hyg (2009) 2.27
High diabetes prevalence among tuberculosis cases in Kerala, India. PLoS One (2012) 2.21
Strategies to improve patient retention on antiretroviral therapy in sub-Saharan Africa. Trop Med Int Health (2010) 2.19
Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings. Curr Opin HIV AIDS (2010) 2.14
In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy. AIDS (2006) 2.11
Operational challenges in diagnosing multi-drug resistant TB and initiating treatment in Andhra Pradesh, India. PLoS One (2011) 2.10
Excellent outcomes among HIV+ children on ART, but unacceptably high pre-ART mortality and losses to follow-up: a cohort study from Cambodia. BMC Pediatr (2009) 2.10
How did the TB patients reach DOTS services in Delhi? A study of patient treatment seeking behavior. PLoS One (2012) 2.07
Scaling up antiretroviral therapy in Malawi-implications for managing other chronic diseases in resource-limited countries. J Acquir Immune Defic Syndr (2009) 1.91
Mortality reduction associated with HIV/AIDS care and antiretroviral treatment in rural Malawi: evidence from registers, coffin sales and funerals. PLoS One (2010) 1.89
Malawi's contribution to "3 by 5": achievements and challenges. Bull World Health Organ (2007) 1.89
A global framework for action to improve the primary care response to chronic non-communicable diseases: a solution to a neglected problem. BMC Public Health (2009) 1.87
Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi. Bull World Health Organ (2004) 1.86
Scaling-up co-trimoxazole prophylaxis in HIV-exposed and HIV-infected children in high HIV-prevalence countries. Lancet Infect Dis (2007) 1.85
Applying lessons learnt from the 'DOTS' Tuberculosis Model to monitoring and evaluating persons with diabetes mellitus in Blantyre, Malawi. Trop Med Int Health (2011) 1.85
CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates. Nat Med (2011) 1.83
High prevalence of lipoatrophy among patients on stavudine-containing first-line antiretroviral therapy regimens in Rwanda. Trans R Soc Trop Med Hyg (2007) 1.82
A public health approach to rapid scale-up of antiretroviral treatment in Malawi during 2004-2006. J Acquir Immune Defic Syndr (2008) 1.81
A national survey of teachers on antiretroviral therapy in Malawi: access, retention in therapy and survival. PLoS One (2007) 1.80
Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. Lancet (2010) 1.69
Risk factors for early mortality in children on adult fixed-dose combination antiretroviral treatment in a central hospital in Malawi. AIDS (2007) 1.68
Keeping health facilities safe: one way of strengthening the interaction between disease-specific programmes and health systems. Trop Med Int Health (2010) 1.66
Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis. Clin Infect Dis (2010) 1.66
What are the reasons for poor uptake of HIV testing among patients with TB in an Eastern India District? PLoS One (2013) 1.65
Source of previous treatment for re-treatment TB cases registered under the National TB control Programme, India, 2010. PLoS One (2011) 1.65
Risk factors for treatment default among re-treatment tuberculosis patients in India, 2006. PLoS One (2010) 1.64
How do patients who fail first-line TB treatment but who are not placed on an MDR-TB regimen fare in South India? PLoS One (2011) 1.64
Cohort monitoring of persons with hypertension: an illustrated example from a primary healthcare clinic for Palestine refugees in Jordan. Trop Med Int Health (2012) 1.60
Screening of patients with tuberculosis for diabetes mellitus in China. Trop Med Int Health (2012) 1.58
A national survey of the impact of rapid scale-up of antiretroviral therapy on health-care workers in Malawi: effects on human resources and survival. Bull World Health Organ (2007) 1.53
Very early mortality in patients starting antiretroviral treatment at primary health centres in rural Malawi. Trop Med Int Health (2009) 1.51
Mortality and loss to follow-up in the first year of ART: Malawi national ART programme. AIDS (2012) 1.50
Adapting the DOTS framework for tuberculosis control to the management of non-communicable diseases in sub-Saharan Africa. PLoS Med (2008) 1.49
AIDS and tuberculosis in medical inpatients in Malawi. Trop Doct (2003) 1.47
Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives. Lancet Infect Dis (2010) 1.47
Stavudine- and nevirapine-related drug toxicity while on generic fixed-dose antiretroviral treatment: incidence, timing and risk factors in a three-year cohort in Kigali, Rwanda. Trans R Soc Trop Med Hyg (2009) 1.47
Micronutrient malnutrition and wasting in adults with pulmonary tuberculosis with and without HIV co-infection in Malawi. BMC Infect Dis (2004) 1.41
Is it relevant to screen women younger than 26 years for precancerous and malignant cervical lesions ? Asian Pac J Cancer Prev (2005) 1.39
Linkage of presumptive multidrug resistant tuberculosis (MDR-TB) patients to diagnostic and treatment services in Cambodia. PLoS One (2013) 1.38
Research to policy and practice change: is capacity building in operational research delivering the goods? Trop Med Int Health (2014) 1.38
Cohort monitoring - as a tool to improve diabetes care services. Diabetes Res Clin Pract (2013) 1.38
Ethics of conducting research in conflict settings. Confl Health (2009) 1.34
The next generation of the World Health Organization's global antiretroviral guidance. J Int AIDS Soc (2013) 1.34
Treatment outcomes stratified by baseline immunological status among young children receiving nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resource-limited settings. Clin Infect Dis (2007) 1.34
Ebola outbreak in rural West Africa: epidemiology, clinical features and outcomes. Trop Med Int Health (2015) 1.33
Tuberculosis management practices by private practitioners in Andhra Pradesh, India. PLoS One (2013) 1.33
Who is accessing antiretroviral therapy during national scale-up in Malawi? Trans R Soc Trop Med Hyg (2006) 1.32
An updated systematic review and meta-analysis on the treatment of active tuberculosis in patients with HIV infection. Clin Infect Dis (2012) 1.31
Impact on ART initiation of point-of-care CD4 testing at HIV diagnosis among HIV-positive youth in Khayelitsha, South Africa. J Int AIDS Soc (2013) 1.28
Screening patients with diabetes mellitus for tuberculosis in China. Trop Med Int Health (2012) 1.27
Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa. AIDS (2012) 1.26
Is Option B+ the best choice? Lancet (2013) 1.24
The vital signs of chronic disease management. Trans R Soc Trop Med Hyg (2009) 1.24
Tuberculosis contact screening and isoniazid preventive therapy in a South Indian district: operational issues for programmatic consideration. PLoS One (2011) 1.24
HIV prevalence among persons suspected of tuberculosis: policy implications for India. J Acquir Immune Defic Syndr (2012) 1.23
Cohort monitoring of persons with diabetes mellitus in a primary healthcare clinic for Palestine refugees in Jordan. Trop Med Int Health (2012) 1.23
Antiretroviral drug supply challenges in the era of scaling up ART in Malawi. J Int AIDS Soc (2011) 1.22
HIV and tuberculosis--science and implementation to turn the tide and reduce deaths. J Int AIDS Soc (2012) 1.21
Contribution of medical colleges to tuberculosis control in India under the Revised National Tuberculosis Control Programme (RNTCP): lessons learnt & challenges ahead. Indian J Med Res (2013) 1.21
Feasibility and effectiveness of provider initiated HIV testing and counseling of TB suspects in Vizianagaram district, South India. PLoS One (2012) 1.20